FISC Norfolk Acq Group, Hampton Roads Detachment, 1968 Gilbert St., Suite 600, Norfolk, VA 23511-3392

Q -- PHARMACEUTICAL RETURN PROGRAM SOL N00189-00-R-0025 DUE 020700 POC Julie Gordon, 757-443-1385 1. The combined synopsis solicitation in section 2 of Amendment 004 of the subject solicitation is hereby changed as follows: The text within paragraph 4 of section 2 is changed as follows: FROM: Within the technical approach evaluation factor, the Government will consider the following subfactors: a) proposed approach and methodology (i.e., ability to convert NDC to NSN codes; assemblage of medical allowance list [AMAL]; proposed time and manpower savings; proposed disposal process; proposed shipping process; proposed return program, inclusive of credit received program; proposed utilization of subcontractors, if any; existing and/or proposed partnerships with pharmaceutical manufacturer(s)/distributor(s) in the local and CONUS areas; proposed training for the fleet, etc.) and b) compliance with all required permits, certifications and/or licenses required by federal, state and local authorities (i.e. EPA, FDA and DEA). The Government will determinate ratings for subfactor (b) of technical approach, compliance with all required permits, certifications and/or licenses, as either acceptable or unacceptable. If the Government rates a contractor as unacceptable within subfactor (b), it will not further evaluate the contractor's proposal. The Government will determine past performance ratings by evaluating the following information which each offeror shall submit: information on the five most recently completed federal, state and/or local government contracts (or other commercial contracts if no government contracts have been awarded to or completed by the offeror), completed in the past five years, which are in any way relevant to the effort required in this solicitation and similar information on any subcontractors which the offeror intends to utilize and points of contact for any existing partner pharmaceutical manufacturer(s)/distributor(s). Offerors shall also include the following for each contract: a)contract number; b)contract period of performance; c)contract type; d)dollar value of the contract; e)detailed description of the work performed; and f)name, activity, position, title and current telephone number (with area code) of the government (or commercial) point of contact for the contract. All Government minimum needs as stated above will be evaluated. TO: Within the technical approach evaluation factor, the Government will consider the following subfactors: a) compliance with all required permits, certifications and/or licenses required by federal, state and local authorities (i.e. EPA, FDA and DEA); and b) proposed approach and methodology (i.e., ability to convert NDC to NSN codes; assemblage of medical allowance list [AMAL]; ability to interface and identify pharmaceutical needs with individual ships; proposed time and manpower savings; proposed disposal process; proposed shipping process; proposed return program, inclusive of credit received program; proposed utilization of subcontractors, if any; existing and/or proposed partnerships with pharmaceutical manufacturer(s)/distributor(s) in the local and CONUS areas; proposed training for the fleet, etc.). The Government will determinate ratings for sub-factor (a) of technical approach, compliance with all required permits, certifications and/or licenses, as either acceptable or unacceptable. If the Government rates a contractor as unacceptable within sub-factor (a), it will not further evaluate the contractor's proposal. The Government will rate all elements within sub-factor (b) on a best value basis. All elements within sub-factor (b) are of equal importance. The Government will determine past performance ratings by evaluating the following information which each offeror shall submit: information on the five most recently completed federal, state and/or local government contracts (or other commercial contracts if no government contracts have been awarded to or completed by the offeror), completed in the past five years, which are in any way relevant to the effort required in this solicitation and similar information on any subcontractors which the offeror intends to utilize and points of contact for any existing partner pharmaceutical manufacturer(s)/distributor(s). Offerors shall also include the following for each contract: a)contract number; b)contract period of performance; c)contract type; d)dollar value of the contract; e)detailed description of the work performed; and f)name, activity, position, title and current telephone number (with area code) of the government (or commercial) point of contact for the contract. The Government will evaluate the past performance of offerors from a best value perspective. The Government will rate the offeror's past performance in regards to their commitment to custo required permits, certifications and/or licenses required by federal, state and local authorities (i.e. EPA, FDA and DEA); mer satisfaction, their timely delivery of quality services at fair and reasonable prices, the existence of symbiotic relationships with partner pharmaceutical manufacturer(s)/distributor(s) and compliance with all applicable federal, state and local regulations. With the exception of sub-factor (a) of technical approach (compliance with all required permits, certifications and/or licenses required by federal, state and local authorities), all Government minimum needs as stated above will be evaluated from a best value perspective. 2. All other terms and conditions of this solicitation remain unchanged. Posted 02/02/00 (W-SN420996). (0033)

Loren Data Corp. http://www.ld.com (SYN# 0048 20000204\Q-0004.SOL)